S100A8 and MALT lymphoma: The prevalence of CagA-expressing strains in patients with MALT lymphoma and gastritis/NUD patients was estimated to be 54.6% (44–64.7 with 95% CIs) and 56.4% (41.5–70.3 with 95% CIs), respectively.